A new article from the RADAR-AD consortium was published in the Journal “Frontiers in Neuroscience”. The paper describes the role of Heart Rate Variability (HRV) (i.e. a measure of the variation in time between each heartbeat) in the future of remote digital biomarkers. It explains that Remote Measurement Technologies (RMTs), such as smartphones, wearables and home-based devices, as used in RADAR-AD, could complement current clinical practice and offer new insights into the activities of daily living, therapeutic interventions and behavioural tasks. The RMTs which measure HRV have the potential to identify digital biomarkers indicative of changes in health or disease. This could promote a more proactive and holistic approach to diagnosis and care in dementia.
Read more here:
https://www.radar-ad.org/newsroom/new-publication-radar-ad-consortium
